The relationship of PrEP beliefs to perceived personal, interpersonal and structural benefits and barriers to PrEP use in women who inject drugs

Author:

Paulus Kirsten,Kelly Patrick J.A.,Brajuha Jesse,D’Avanzo Paul,Dauria Emily F.,Trainor Aurora,Alrez Annabelle,Bass Sarah Bauerle

Abstract

Abstract Background Women who inject drugs (WWID) have significant biological, behavioral, and gender-based barriers to accessing HIV prevention services, including Pre-Exposure Prophylaxis (PrEP) medication. Little is known about how beliefs about PrEP impact both perceived barriers and benefits of PrEP use and how they may be related to the decision-making process. Methods Surveys were conducted with 100 female clients of a large syringe services program in Philadelphia, Pennsylvania. The sample was categorized into three groups based on mean PrEP beliefs scores using terciles: accurate beliefs, moderately accurate beliefs, and inaccurate beliefs. Oneway ANOVA tests were used to compare groups by perceived benefits and barriers to PrEP, drug use stigma, healthcare beliefs, patient self-advocacy, and intention to use PrEP. Results Participants had a mean age of 39 years (SD 9.00), 66% reported being White, 74% finished high school, and 80% reported having been homeless within the past 6 months. Those with the most accurate PrEP beliefs reported highest intent to use PrEP and were more likely to agree that benefits of PrEP included it preventing HIV and helping them “feel in charge”. Those with inaccurate beliefs were more likely to strongly agree that barriers, such as fear of reprisal from a partner, potential theft, or feeling they “might get HIV anyway”, were reasons not to use PrEP. Conclusions Results indicate perceived personal, interpersonal and structural barriers to PrEP use are associated with accuracy of beliefs is, pointing to important intervention targets to increase uptake among WWID.

Funder

National Institute on Drug Abuse

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology,Reproductive Medicine,General Medicine

Reference35 articles.

1. Joint United Nations Programme on HIV/AIDS. HIV prevention among injecting drug users [Internet]. Joint United Nations Programme on HIV/AIDS. United Nations Economic and Social Council; 2009 [cited 2022 May 14]. Available from: https://www.unaids.org/sites/default/files/sub_landing/20090518_hiv_prevention_among_idus_final_en.pdf.

2. U.S. statistics [Internet]. U.S. Department of Health & Human Services; 2022 [cited 2022 July 13]. Available from: https://www.hiv.gov/hiv-basics/overview/data-and-trends/statistics.

3. HIV in the United States. and dependent areas [Internet]. Centers for Disease Control and Prevention. Centers for Disease Control and Prevention; 2021 [cited 2022 May 19]. Available from: https://www.cdc.gov/hiv/statistics/overview/ataglance.html.

4. HIV and people who inject drugs [Internet]. Centers for Disease Control and Prevention. Centers for Disease Control and Prevention; 2022 [cited 2022 July 13]. Available from: https://www.cdc.gov/hiv/group/hiv-idu.html.

5. HIV and women [Internet]. Centers for Disease Control and Prevention. Centers for Disease Control and Prevention; 2022. [cited 2022 May 20].

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3